publicações selecionadas
-
artigo de revista
- Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer. Oncotarget. 2018
- Competing-risks regression models in analysis of biomarkers as predictors of high-risk human papillomavirus (HPV) infection outcomes and incident CIN in the LAMS cohort. International Journal of Gynecological Pathology. 2013
- Optional screening strategies for cervical cancer using standalone tests and their combinations among low- and medium-income populations in Latin America and Eastern Europe. Journal of Medical Screening. 2010
- Up-regulation of 14-3-3s (stratifin) is associated with high-grade CIN and high-risk human papillomavirus (HPV) at baseline but does not predict outcomes of HR-HPV infections or incident CIN in the LAMS* study. American Journal of Clinical Pathology. 2010
- Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasia. American Journal of Clinical Pathology. 2010
- p300 expression is related to high-risk human papillomavirus infections and severity of cervical intraepithelial neoplasia but not to viral or disease outcomes in a longitudinal setting. International Journal of Gynecological Pathology. 2010
- Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort. Virchows Archiv. 2009
- Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the new independent states of the former soviet union and the latin american screening study cohorts. International Journal of Gynecological Cancer. 2009
- Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CIN. American Journal of Clinical Pathology. 2009
- Value of conventional pap smear, liquid-based cytology, visual inspection and human papillomavirus testing as optional screening tools among latin american women <35 and = 35 years of age: experience from the Latin American Screening Study. Acta Cytologica. 2008